Search Results - Peter D’Andrea

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study

    Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study by Kai-Michael Beeh, Stephanie Korn, Jutta Beier, Dalal Jadayel, Michelle Henley, Peter D’Andrea, Donald Banerji

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients

    Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients by Jadwiga A. Wedzicha, Ronald Dahl, Roland Buhl, Agnes Annette Schubert-Tennigkeit, Hungta Chen, Peter D’Andrea, Robert Fogel, Donald Banerji

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease

    Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease by James F. Donohue, Paul Jones, Christian Bartels, Jessica Marvel, Peter D’Andrea, Donald Banerji, David G. Morris, Francesco Patalano, Robert Fogel

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

    A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study by Kenneth R. Chapman, Kai Michael Beeh, Jutta Beier, Eric Bateman, Anthony D’Urzo, Robert Nutbrown, Michelle Henley, Hungta Chen, Tim Overend, Peter D’Andrea

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

    Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma... by Huib A.M. Kerstjens, Jorge Máspero, Kenneth R. Chapman, Richard N. van Zyl-Smit, Motoi Hosoe, Ana-Maria Tanase, Catherine Lavecchia, Abhijit Pethe, Xu Shu, Peter D’Andrea

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: